Phosphagenics to Exhibit at Jefferies Healthcare Conference
MELBOURNE, Australia, June 19 /PRNewswire-FirstCall/ -- Phosphagenics Limited (ASX: POH) (AIM: PSG) (ADR/OTC: PPGNY) announced today that Harry Rosen, Chief Executive Officer, and Dr. Esra Ogru, Executive Vice President, will host a table-top presentation around the Jefferies Healthcare Conference at the conference reception being held at Per Se in the Time Warner Center in New York on Wednesday, June 27th, 2007 from 5:00 PM to 8:00 PM ET. In addition, the Company will be available for one-on-one meetings during the week of the conference. About Phosphagenics Limited Phosphagenics is a Melbourne-based, globally driven biotechnology company focused on the discovery of new and cost effective ways to enhance the bioavailability, activity, safety and delivery of proven pharmaceutical and nutraceutical products. The Company's core technology is built around the science and application of phosphorylation, a process where the addition of a phosphate group has been found to enhance the bioavailability, activity and safety of existing pharmaceuticals and nutraceuticals, as well as to assist in the production of drug delivery platforms. Phosphagenics' shares are listed on the Australian Stock Exchange (POH) and the London Stock Exchange's Alternative Investment Market (PSG). An ADR - Level 1 program has been established in the US with the Bank of New York (PPGNY) for US investors to trade in Phosphagenics' stock on the 'over-the-counter' market. For more information, please visit Phosphagenics' web site at www.phosphagenics.com
SOURCE Phosphagenics Limited
More by this Source
Phosphagenics' Oxymorphone Patch Success
Oct 24, 2013, 08:00 ET
Browse our custom packages or build your own to meet your unique communications needs.
Learn about PR Newswire services
Request more information about PR Newswire products and services or call us at (888) 776-0942.